Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.（PLRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PLRX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
4
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Pliant Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PLRX 季度内部人买卖趋势
PLRX 内幕交易卖出 · PLRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · PLRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PLRX 高管卖出股份 · PLRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 20, 2026 | Cummings Keith Lamont CFO | Sale | 24,002 | $31K | Form 4 |
| Jan 20, 2026 | Cheung Lily Chief Human Resource Officer | Sale | 7,534 | $10K | Form 4 |
| Jan 20, 2026 | Coulie Bernard President and CEO · Director | Sale | 89,375 | $114K | Form 4 |
| Jan 20, 2026 | Kuo Minnie COO | Sale | 6,917 | $9K | Form 4 |
| Jan 23, 2025 | Cheung Lily Chief Human Resource Officer | Award | 25,875 | — | Form 4 |
| Jan 23, 2025 | Ouimette Mike General Counsel & Corp. Sec'y | Award | 35,000 | — | Form 4 |
| Jan 23, 2025 | Hull Hans Chief Business Officer | Award | 40,150 | — | Form 4 |
| Jan 23, 2025 | Lefebvre Eric Chief Medical Officer | Award | 45,650 | — | Form 4 |
| Jan 23, 2025 | Cummings Keith Lamont CFO | Award | 56,650 | — | Form 4 |
| Jan 23, 2025 | Coulie Bernard President and CEO · Director | Award | 162,500 | — | Form 4 |
| Jan 17, 2025 | Coulie Bernard President and CEO · Director | Sale | 52,419 | $587K | Form 4 |
| Jan 17, 2025 | Cummings Keith Lamont CFO | Sale | 20,148 | $226K | Form 4 |
| Jan 17, 2025 | Hull Hans Chief Business Officer | Sale | 15,936 | $179K | Form 4 |
| Jan 17, 2025 | Lefebvre Eric Chief Medical Officer | Sale | 18,478 | $207K | Form 4 |
| Jan 17, 2025 | Cheung Lily Chief Human Resource Officer | Sale | 3,740 | $42K | Form 4 |
| Jan 17, 2025 | Ouimette Mike General Counsel & Corp. Sec'y | Sale | 13,270 | $149K | Form 4 |
| Jan 22, 2025 | Ouimette Mike General Counsel & Corp. Sec'y | Sale | 10,230 | $112K | Form 4 |
| Jul 10, 2024 | Lefebvre Eric Chief Medical Officer | Sale | 12,319 | $142K | Form 4 |
| Jul 10, 2024 | Hull Hans Chief Business Officer | Sale | 9,900 | $114K | Form 4 |
| Jul 10, 2024 | Cummings Keith Lamont CFO | Sale | 10,911 | $126K | Form 4 |
| Jul 10, 2024 | Coulie Bernard President and CEO · Director | Sale | 38,710 | $447K | Form 4 |
| Jul 10, 2024 | Ouimette Mike General Counsel & Corp. Sec'y | Sale | 7,656 | $89K | Form 4 |
| Jul 9, 2024 | Lefebvre Eric Chief Medical Officer | Award | 24,063 | — | Form 4 |
| Jul 9, 2024 | Hull Hans Chief Business Officer | Award | 19,337 | — | Form 4 |
| Jul 9, 2024 | Cummings Keith Lamont CFO | Award | 21,313 | — | Form 4 |
Coulie Bernard
President and CEO · Director
日期
Jan 17
股数
52,419
均价
$11.20
总金额
$587K
Ouimette Mike
General Counsel & Corp. Sec'y
日期
Jan 17
股数
13,270
均价
$11.20
总金额
$149K
Ouimette Mike
General Counsel & Corp. Sec'y
日期
Jan 22
股数
10,230
均价
$10.99
总金额
$112K
Coulie Bernard
President and CEO · Director
日期
Jul 10
股数
38,710
均价
$11.56
总金额
$447K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PLRX 内幕交易
PLRX 内幕交易
Pliant Therapeutics, Inc.（PLRX）内幕交易数据来源于公司内部人（包括Cummings Keith Lamont (CFO), Cheung Lily (Chief Human Resource Officer), Coulie Bernard (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。PLRX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Pliant Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PLRX 内幕交易 · 5个问题Pliant Therapeutics, Inc.（PLRX）的内部人包括高管和董事，如Cummings Keith Lamont (CFO), Cheung Lily (Chief Human Resource Officer), Coulie Bernard (President and CEO · Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026